Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

Presentation TCT Abstracts Posters 2018

Left Ventricular End Diastolic Pressure (LVEDP) and TAVR Outcomes

Presenter: Abdul Rahman

September 25, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Conference News PCR London Valves 2018

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

Shelley Wood

September 10, 2018

News Daily News

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

L.A. McKeown

August 20, 2018

News Daily News

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Michael O'Riordan

August 08, 2018

News Conference News The Structural Heart Disease Summit 2018

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Todd Neale

February 16, 2018

News Conference News ISET 2018

Next-Generation Large-Bore Closure Devices Arrive

Caitlin E. Cox

February 05, 2018

News Daily News

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Michael O'Riordan

February 01, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

News Daily News

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Michael O'Riordan

January 10, 2018

News Daily News

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

L.A. McKeown

January 04, 2018

Advertisement

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Left Ventricular End Diastolic Pressure (LVEDP) and TAVR Outcomes

High Mortality but Durable Results With Valve-in-Valve TAVR

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Next-Generation Large-Bore Closure Devices Arrive

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content